Guerbet Honored With Supplier Horizon Award from Premier Inc.

News provided by

Jun 23, 2016, 07:00 ET

PRINCETON, N.J., June 23, 2016 /PRNewswire/ -- Guerbet announced today that it has been named a winner of Premier Inc.'s Supplier Horizon Award.

One of 12 suppliers to receive the award this year, Guerbet was recognized for its support of Premier members through exceptional local customer service and engagement, value creation through clinical excellence, and commitment to lower costs.

"We are delighted to receive this recognition of our outstanding customer service from Premier," says Massimo Carrara, General Manager, Guerbet US. "With the recent acquisition of Mallinckrodt's contrast media and delivery systems (CMDS) division, we are working hard to deliver supply chain excellence to global customers. We are very pleased to offer products new to Guerbet, and to expand the reach of longstanding products like Dotarem™ (gadoterate meglumine) Injection, which was introduced in the US in 2013."

Guerbet specializes in contrast agents, medical devices and innovative solutions for use in diagnostic imaging and interventional radiology. Last year's acquisition of Mallinckrodt's CMDS division doubled the company's size and solidified their standing as a global leader in medical imaging and contrast media. Guerbet is now present in 80 countries via a network of subsidiaries and distributors, with a workforce of 2,500 and pro forma revenue of €789 million in 2015.

Guerbet accepted the award at Premier's 2016 Breakthroughs Conference and Exhibition in National Harbor, MD on June 22.

"Guerbet supports Premier members by offering valuable products and services that help to lower supply chain costs and improve operating efficiencies," said Durral R. Gilbert, president of supply chain services, Premier. "We're honored to recognize them as a Horizon Award recipient."

About Premier Inc.
Premier Inc. is a leading healthcare improvement company, uniting an alliance of approximately 3,600 U.S. hospitals and 120,000 other providers to transform healthcare. With integrated data and analytics, collaboratives, supply chain solutions, and advisory and other services, Premier enables better care and outcomes at a lower cost. Premier, a Malcolm Baldrige National Quality Award recipient, plays a critical role in the rapidly evolving healthcare industry, collaborating with members to co-develop long-term innovations that reinvent and improve the way care is delivered to patients nationwide. Headquartered in Charlotte, N.C., Premier is passionate about transforming American healthcare. Please visit Premier's news and investor sites on www.premierinc.com for more information about the company.

About Guerbet
Guerbet is a pioneer in the contrast agent field with nearly 90 years' experience, and is the only pharmaceutical group dedicated to medical imaging worldwide. It offers a comprehensive range of X-Ray, Magnetic Resonance Imaging (MRI) and Interventional Radiology and Theranostics (IRT) products, along with a range of injectors and related medical devices to improve the diagnosis and treatment of patients. To discover new products and ensure future growth, Guerbet invests heavily in R&D, spending around 9% of its sales each year. Guerbet (GBT) is listed on Euronext Paris (Segment B – Mid Caps) and generated pro forma revenue of €789M in 2015.
For more information about Guerbet please visit www.guerbet.com.

Forward-looking statements
This press release may contain forward-looking statements based on current assumptions and forecasts made by Guerbet Group management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performances of the company and the estimates given here. These factors include those discussed in Guerbet's public reports which are available on the Guerbet website at www.guerbet.com. The company assumes no liability whatsoever to update these forward-looking-statements or to conform them to future events or developments.

SOURCE Guerbet